Invasive pneumococcal disease in western Sydney, 2002–2010
Kristina L. Flego A C , George Truman A , Vicky Sheppeard A and Robin E. Gilmour B
+ Author Affiliations
- Author Affiliations
A Centre for Population Health, Clinical Support Division Western
B Communicable Diseases Branch, NSW Department of Health
C Corresponding author. Email: Kristina.Flego@swahs.health.nsw.gov.au
NSW Public Health Bulletin 22(12) 219-221 https://doi.org/10.1071/NB11012
Published: 22 December 2011
References
[1] Department of Health and Ageing Vaccine Preventable Diseases in Australia, 2005–2007. Commun Dis Intell 2010; 34[2] Health NSW. Response Protocol for NSW Public Health Units. Pneumococcal Disease (Invasive). September 2004. Available from: http://www.health.nsw.gov.au/factsheets/guideline/pneumo.html (Cited 27 May 2011.)
[3] Isaacman DJ, Fletcher MA, Fritzell B, Ciuryla V, Shranz J. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7;Prevenar). Vaccine 2007; 25 2420–7..
| Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7;Prevenar).Crossref | GoogleScholarGoogle Scholar |
[4] Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006; 24 468–75.
| Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD28XkvVak&md5=88d61d190c794e565492df7a01eecaecCAS |
[5] Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Changing epidemiology of invasive pneumococcal disease in Canada, 1998–2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 2009; 49 205–12.
| Changing epidemiology of invasive pneumococcal disease in Canada, 1998–2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.Crossref | GoogleScholarGoogle Scholar |
[6] Sydney West Immunisation Strategy 2010–13. Parramatta: Centre for Population Health; 2010.
[7] Dias R, Caniça M. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol 2007; 51 35–42.
| Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXhtFeksrrI&md5=2df51e6ce87474820d4f239e1c47ba23CAS |
[8] Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010; 16 217–25.
[9] Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambersten L, Kaltoft M., et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 2010; 50 329–37.
| Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.Crossref | GoogleScholarGoogle Scholar |
[10] Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in anitmicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010; 16 402–10.
| Changes in anitmicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.Crossref | GoogleScholarGoogle Scholar |
